Evidence map›Paper›PMID 30652612›Full record

ArticleJCO clinical cancer informatics2018

Assessing the Training and Research Environment for Genomics, Bioinformatics, and Immunology in Radiation Oncology.

Kent W Mouw, Tyler F Beck, Judith C Keen, Adam P Dicker

Abstract read
In one paragraph

Article in JCO clinical cancer informatics, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Trial
  2. Article
  3. In Regard to Wallner et al.International journal of radiation oncology, biology, physics · 2020
    Article
  4. Article
  5. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

4 authors.

Kent W MouwKent W. Mouw, Brigham and Women's Hospital/Dana-Farber Cancer Institute, Boston, MA; Tyler F. Beck and Judith C. Keen, American Society for Radiation Oncology, Arlington, VA; and Adam P. Dicker, Sidney Kimmel Medical College and Cancer Center, Thomas Jefferson University, Philadelphia, PA.
Tyler F BeckKent W. Mouw, Brigham and Women's Hospital/Dana-Farber Cancer Institute, Boston, MA; Tyler F. Beck and Judith C. Keen, American Society for Radiation Oncology, Arlington, VA; and Adam P. Dicker, Sidney Kimmel Medical College and Cancer Center, Thomas Jefferson University, Philadelphia, PA.
Judith C KeenKent W. Mouw, Brigham and Women's Hospital/Dana-Farber Cancer Institute, Boston, MA; Tyler F. Beck and Judith C. Keen, American Society for Radiation Oncology, Arlington, VA; and Adam P. Dicker, Sidney Kimmel Medical College and Cancer Center, Thomas Jefferson University, Philadelphia, PA.
Adam P DickerKent W. Mouw, Brigham and Women's Hospital/Dana-Farber Cancer Institute, Boston, MA; Tyler F. Beck and Judith C. Keen, American Society for Radiation Oncology, Arlington, VA; and Adam P. Dicker, Sidney Kimmel Medical College and Cancer Center, Thomas Jefferson University, Philadelphia, PA.

Funding

X-Ray Crystallography and Macromolecular CharacterizationP30CA056036 · NCI · THOMAS JEFFERSON UNIVERSITY · PI Andrew Chapman · 1995 to 2026
$94.8M
Investigating the effect of ERCC2 mutations on DNA repair capacity and chemo-radiotherapy response in muscle-invasive bladder cancerK08CA219504 · NCI · DANA-FARBER CANCER INST · PI MOUW, KENT W · 2017 to 2021
$885k
NCI NIH HHS K08 CA219504NCI NIH HHS P30 CA056036Wellcome Trust
6 · The paper itself

Abstract

purposeTo assess radiation oncologists' perceptions of training and research opportunities in the fields of genomics, bioinformatics, and immunology. MATERIALS AND

methodsA 13-item electronic survey was sent to 101 radiation oncology department chairs and administrators. A separate 30-item electronic survey was sent to 132 members of the American Society for Radiation Oncology Science Council as well as to 565 members of the Association of Residents in Radiation Oncology. Survey responses were collected, and results were analyzed using descriptive statistics.

resultsTwenty-six department chairs and 91 general respondents submitted responses. Among general respondents, 69% were current trainees and 31% had completed training. The majority of respondents (92%) were affiliated with an academic/university main campus. Approximately half of respondents (43% to 53%) reported no prior formal training in bioinformatics, genomics, or immunology. More than half of department chairs (54% to 58%) and general respondents (57% to 63%) thought that current training opportunities in these areas were absolutely or moderately insufficient. A majority of respondents (53% to 65%) thought that additional training in these areas would provide opportunity for career advancement, and 80% could identify a current or future research project that additional training in these fields would allow them to pursue. More than half of respondents expressed interest in attending a formal training course, and the majority of department chairs (22 of 26 [85%]) reported that they would probably or definitely send trainees or faculty members to a formal training course.

conclusionAmong radiation oncologists surveyed, there is a perceived lack of current training opportunities in bioinformatics, genomics, and immunology. A majority of respondents reported an interest in obtaining additional training in these areas and believed that training would provide opportunity for career advancement.

Indexed as

Allergy and ImmunologyBiomedical ResearchComputational BiologyEducation, MedicalGenomicsHumansRadiation Oncology

Identifiers

PMID30652612
PMCPMC6874041

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.